Clincosm LogoSign in Get a demo

nf1

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group

Not yet recruiting
  • Neurofibromatosis 1
  • +2 more
  • Test group (Group A): FCN-159 8 mg, orally, once daily;
  • Control group (Group B): Placebo, orally, once daily;
  • (no location specified)
Jun 16, 2023

NF1, Neurofibromatosis, Plexiform Neurofibromas Trial in United States (Cabozantinib)

Active, not recruiting
  • NF1
  • +2 more
  • Los Angeles, California
  • +11 more
Jan 13, 2023

NF1, Low-grade Glioma Trial in United States (Poly ICLC)

Recruiting
  • NF1
  • Low-grade Glioma
  • Poly ICLC
  • Birmingham, Alabama
  • +18 more
Jan 5, 2023

Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

Active, not recruiting
  • Neurofibromatosis 1
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial in China, Spain, United States (FCN-159)

Recruiting
  • Neurofibromatosis 1
  • +2 more
  • Los Angeles, California
  • +11 more
Jul 25, 2022

MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

Not yet recruiting
  • MPNST
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jun 29, 2022

Neurofibromatosis 1, NF1, Neurofibromatosis Type 1 Trial in Chicago

Recruiting
  • Neurofibromatosis 1
  • +2 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Mar 11, 2022

    NF1, Congenital Pseudarthrosis of Tibia Trial in Australia, United States (INFUSE Bone Graft (BMP-2), Control Group)

    Terminated
    Has Results
    • NF1
    • Congenital Pseudarthrosis of Tibia
    • INFUSE Bone Graft (BMP-2)
    • Control Group
    • Birmingham, Alabama
    • +15 more
    Sep 29, 2021

    Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

    Completed
    • Plexiform Neurofibromas
    • NF1
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      May 1, 2020

      Adaptation and Quality of Life Among Neurofibromatosis Type I

      Completed
      • Neurofibromatosis Type 1
      • +2 more
        • Bethesda, Maryland
          National Human Genome Research Institute (NHGRI), 9000 Rockville
        Dec 13, 2019

        Neurofibromatosis, NF1, Plexiform Neurofibromas Trial in Indianapolis (Sutent®/Sunitinib)

        Terminated
        Has Results
        • Neurofibromatosis
        • +2 more
        • Indianapolis, Indiana
          Riley Hospital for Children at IU Health
        Feb 14, 2018

        Neurofibromatosis, NF1, Neurofibromas Trial in Indianapolis (Tasigna)

        Completed
        Has Results
        • Neurofibromatosis
        • +2 more
        • Indianapolis, Indiana
          Riley Hospital for Children
        Apr 11, 2017